AstraZeneca - July 2022 - case study 2
Start date:
Supporting and optimising treatment of Asthma patients in a Severe Asthma setting by objectively measuring adherence through the introduction of Turbu+, a digital intervention
Last modified: 29 May 2024
Last reviewed: 29 May 2024